Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/25/2025

Naltrexone for Excessive Masturbation: Guideline Recommendations and Evidence Analysis

Introduction to Naltrexone and Excessive Masturbation

  • The American Urological Association guidelines for sexual dysfunction do not mention naltrexone or opioid antagonists as treatment options for excessive masturbation in the general population 4, 5

Evidence Analysis and Guideline Support

  • Available guidelines focus exclusively on naltrexone's FDA-approved indications: opioid dependence and alcohol use disorder, with no established clinical guidelines addressing naltrexone for excessive masturbation or compulsive sexual behaviors in non-offender populations 1, 2, 3
  • The primary outcome should be patient satisfaction and quality of life, not simply behavior suppression, according to the American Urological Association 4
  • Cognitive behavioral therapy is the evidence-based approach for impulse control and compulsive behaviors without medication side effects, as recommended by Praxis Medical Insights 3
  • Selective serotonin reuptake inhibitors (SSRIs) have established efficacy for impulse control disorders and obsessive-compulsive spectrum conditions without the sexual dysfunction profile of naltrexone, with guideline-supported dosages including paroxetine 10-40 mg/day, sertraline 25-200 mg/day, and fluoxetine 5-20 mg/day 4, 5, 7

Safety Concerns and Monitoring

  • Naltrexone requires baseline and ongoing liver function monitoring every 3-6 months due to hepatotoxicity risk, with common side effects including headache, tachycardia, vivid dreams, nausea, and gastrointestinal symptoms 3, 6